CONDENSED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,697,931)	$ (5,153,948)
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization	190,012	161,302
Stock-based compensation expense	354,441	84,608
Change in fair value of warrants	0	297,547
Changes in operating assets and liabilities:
Accounts receivable, net	(5,926)	31,685
Receivable from related party	499,987	550,297
Inventory	23,248	25,682
Prepaid expenses and other current assets	115,005	(139,215)
Accounts payable	(537,561)	628,154
Accrued expenses	(66,011)	25,578
Deferred revenue	(752,212)	164,920
Deferred Liability	3,787	0
Net cash used in operating activities	(4,873,161)	(3,323,390)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital additions	(92,278)	(273,653)
Net cash used in investing activities	(92,278)	(273,653)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from private placement of common stock	0	12,000,000
Private placement offering costs	0	(988,626)
Proceeds from exercises of employee stock options	0	80,520
Proceeds from employee stock purchase plan	27,557	23,232
Net cash provided by financing activities	27,557	11,115,126
Net increase (decrease) in cash and cash equivalents	(4,937,882)	7,518,083
Cash and cash equivalents, beginning of period	7,542,281	1,225,426
Cash and cash equivalents, end of period	2,604,399	8,743,509
Supplemental disclosures of cash flow information:
Cash paid for interest	0	219,914
Supplemental disclosures of non-cash financing activities:
Interest related to fair value of warrants market adjustment	$ 0	$ 297,547